These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 22689290)

  • 21. Treatment of Bipolar Depression with Deep TMS: Results from a Double-Blind, Randomized, Parallel Group, Sham-Controlled Clinical Trial.
    Tavares DF; Myczkowski ML; Alberto RL; Valiengo L; Rios RM; Gordon P; de Sampaio-Junior B; Klein I; Mansur CG; Marcolin MA; Lafer B; Moreno RA; Gattaz W; Daskalakis ZJ; Brunoni AR
    Neuropsychopharmacology; 2017 Dec; 42(13):2593-2601. PubMed ID: 28145409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcranial magnetic stimulation in the acute treatment of major depressive disorder: clinical response in an open-label extension trial.
    Avery DH; Isenberg KE; Sampson SM; Janicak PG; Lisanby SH; Maixner DF; Loo C; Thase ME; Demitrack MA; George MS
    J Clin Psychiatry; 2008 Mar; 69(3):441-51. PubMed ID: 18294022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized double-blind crossover trial of deep brain stimulation of the subcallosal cingulate gyrus in patients with treatment-resistant depression: a pilot study of relapse prevention.
    Puigdemont D; Portella M; Pérez-Egea R; Molet J; Gironell A; de Diego-Adeliño J; Martín A; Rodríguez R; Àlvarez E; Artigas F; Pérez V
    J Psychiatry Neurosci; 2015 Jul; 40(4):224-31. PubMed ID: 25652752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and Safety of Deep Transcranial Magnetic Stimulation in Office Workers with Treatment-Resistant Depression: A Randomized, Double-Blind, Sham-Controlled Trial.
    Matsuda Y; Kito S; Igarashi Y; Shigeta M
    Neuropsychobiology; 2020; 79(3):208-213. PubMed ID: 31955155
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 61% of unmedicated treatment resistant depression patients who did not respond to acute TMS treatment responded after four weeks of twice weekly deep TMS in the Brainsway pivotal trial.
    Yip AG; George MS; Tendler A; Roth Y; Zangen A; Carpenter LL
    Brain Stimul; 2017; 10(4):847-849. PubMed ID: 28330592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A double-blind sham controlled study of right prefrontal repetitive transcranial magnetic stimulation (rTMS): therapeutic and cognitive effect in medication free unipolar depression during 4 weeks.
    Januel D; Dumortier G; Verdon CM; Stamatiadis L; Saba G; Cabaret W; Benadhira R; Rocamora JF; Braha S; Kalalou K; Vicaut PE; Fermanian J
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):126-30. PubMed ID: 16242826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Left prefrontal transcranial magnetic stimulation for treatment-resistant depression in adolescents: a double-blind, randomized, sham-controlled trial.
    Croarkin PE; Elmaadawi AZ; Aaronson ST; Schrodt GR; Holbert RC; Verdoliva S; Heart KL; Demitrack MA; Strawn JR
    Neuropsychopharmacology; 2021 Jan; 46(2):462-469. PubMed ID: 32919400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized controlled trial of transcranial magnetic stimulation in pregnant women with major depressive disorder.
    Kim DR; Wang E; McGeehan B; Snell J; Ewing G; Iannelli C; O'Reardon JP; Sammel MD; Epperson CN
    Brain Stimul; 2019; 12(1):96-102. PubMed ID: 30249416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcranial magnetic stimulation for treatment-resistant depression: Naturalistic treatment outcomes for younger versus older patients.
    Conelea CA; Philip NS; Yip AG; Barnes JL; Niedzwiecki MJ; Greenberg BD; Tyrka AR; Carpenter LL
    J Affect Disord; 2017 Aug; 217():42-47. PubMed ID: 28388464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial.
    O'Reardon JP; Solvason HB; Janicak PG; Sampson S; Isenberg KE; Nahas Z; McDonald WM; Avery D; Fitzgerald PB; Loo C; Demitrack MA; George MS; Sackeim HA
    Biol Psychiatry; 2007 Dec; 62(11):1208-16. PubMed ID: 17573044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice.
    Carpenter LL; Janicak PG; Aaronson ST; Boyadjis T; Brock DG; Cook IA; Dunner DL; Lanocha K; Solvason HB; Demitrack MA
    Depress Anxiety; 2012 Jul; 29(7):587-96. PubMed ID: 22689344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deep transcranial magnetic stimulation over the prefrontal cortex: evaluation of antidepressant and cognitive effects in depressive patients.
    Levkovitz Y; Harel EV; Roth Y; Braw Y; Most D; Katz LN; Sheer A; Gersner R; Zangen A
    Brain Stimul; 2009 Oct; 2(4):188-200. PubMed ID: 20633419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-utility analysis of curative and maintenance repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant unipolar depression: a randomized controlled trial protocol.
    Bulteau S; Laurin A; Volteau C; Dert C; Lagalice L; Schirr-Bonnans S; Bukowski N; Guitteny M; Simons L; Cabelguen C; Pichot A; Tessier F; Bonnin A; Lepage A; ; ; Vanelle JM; Sauvaget A; Riche VP
    Trials; 2020 Apr; 21(1):312. PubMed ID: 32248820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized controlled trial with 4-month follow-up of adjunctive repetitive transcranial magnetic stimulation of the left prefrontal cortex for depression.
    Mogg A; Pluck G; Eranti SV; Landau S; Purvis R; Brown RG; Curtis V; Howard R; Philpot M; McLoughlin DM
    Psychol Med; 2008 Mar; 38(3):323-33. PubMed ID: 17935639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. rTMS with a two-coil array: Safety and efficacy for treatment resistant major depressive disorder.
    Carpenter LL; Aaronson ST; Clarke GN; Holtzheimer PE; Johnson CW; McDonald WM; Stannard EL; Schneider MB
    Brain Stimul; 2017; 10(5):926-933. PubMed ID: 28642024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors associated with response after deep transcranial magnetic stimulation in a real-world clinical setting: Results from the first 40 cases of treatment-resistant depression.
    Feffer K; Lapidus KAB; Braw Y; Bloch Y; Kron S; Netzer R; Nitzan U
    Eur Psychiatry; 2017 Jul; 44():61-67. PubMed ID: 28545010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The expanding evidence base for rTMS treatment of depression.
    George MS; Taylor JJ; Short EB
    Curr Opin Psychiatry; 2013 Jan; 26(1):13-8. PubMed ID: 23154644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significant analgesic effects of one session of postoperative left prefrontal cortex repetitive transcranial magnetic stimulation: a replication study.
    Borckardt JJ; Reeves ST; Weinstein M; Smith AR; Shelley N; Kozel FA; Nahas Z; Byrne KT; Morgan K; George MS
    Brain Stimul; 2008 Apr; 1(2):122-7. PubMed ID: 19759838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Health-related quality of life assessment in depression after low-frequency transcranial magnetic stimulation].
    Dumas R; Boyer L; Richieri R; Guedj E; Auquier P; Lançon C
    Encephale; 2014 Feb; 40(1):74-80. PubMed ID: 24091070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cognitive outcomes of TMS treatment in bipolar depression: Safety data from a randomized controlled trial.
    Myczkowski ML; Fernandes A; Moreno M; Valiengo L; Lafer B; Moreno RA; Padberg F; Gattaz W; Brunoni AR
    J Affect Disord; 2018 Aug; 235():20-26. PubMed ID: 29631203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.